Incyte Says FDA Issued CRL For Ruxolitinib Extended-release Tablets

RTTNews | 707天前
Incyte Says FDA Issued CRL For Ruxolitinib Extended-release Tablets

(RTTNews) - Incyte Corp. (INCY) announced Friday that the U.S. Food and Drug Administration (FDA) has issued a complete response letter for ruxolitinib extended-release (XR) tablets, a JAK1/JAK2 inhibitor, for once-daily (QD) use in the treatment of certain types of myelofibrosis (MF), polycythemia vera (PV) and graft-versus-host disease (GVHD).

The complete response letter states that the FDA cannot approve the application in its present form. The FDA acknowledged that the study submitted in the New Drug Application (NDA) met its objective of bioequivalence based on area under the curve (AUC) parameters but identified additional requirements for approval.

Incyte intends to meet with the FDA to determine appropriate next steps.

The NDA was based on two studies designed to show that ruxolitinib XR tablets are dosage strength proportional and bioequivalent to Jakafi (ruxolitinib) tablets.

read more
Incyte Q4 Adj EPS Misses Estimates, But Revenues Top

Incyte Q4 Adj EPS Misses Estimates, But Revenues Top

Incyte Corp. (INCY) on Tuesday reported net income of $201.10 million or $0.89 per share for the fourth quarter, sharply higher than $28.46 million or $0.13 per share in the prior-year quarter.
RTTNews | 381天前
Incyte Q1 Results Top Estimates

Incyte Q1 Results Top Estimates

Incyte Corp. (INCY) on Tuesday reported net income of $161.43 million or $0.72 per share for the first quarter, up from $149.46 million or $0.67 per share in the prior-year quarter.
RTTNews | 941天前
German Inflation Steady At 2.3% In February

German Inflation Steady At 2.3% In February

Consumer price inflation in Germany was unchanged in February, while the core price growth slowed as the cost of food increased strongly, preliminary data from the statistical office Destatis showed on Friday.
RTTNews | 6小时39分钟前
Canadian Market Modestly Higher In Cautious Trade

Canadian Market Modestly Higher In Cautious Trade

The Canadian benchmark S&P/TSX Composite Index is modestly higher in late afternoon trades on Friday with stocks turning in a mixed performance. Worries about U.S. tariffs and their potential impact on global economic growth appear to be weighing on sentiment. Investors are also digesting the nation's GDP report and U.S. PCE reading.
RTTNews | 6小时53分钟前
Pound Retreats Amid Risk Aversion

Pound Retreats Amid Risk Aversion

The pound pulled back against its most major counterparts in the New York session on Friday, as risk sentiment dampened after a meeting between President Donald Trump and Ukrainian President Volodymyr Zelenskyy devolved into a shouting match.
RTTNews | 6小时56分钟前
Swiss Market Ends On Firm Note

Swiss Market Ends On Firm Note

After a weak start and a subsequent recovery, the Swiss market struggled for direction till mid afternoon on Friday, but gained in strength thanks to some brisk buying at several counters in last ninety minutes of the day's session.
RTTNews | 7小时55分钟前
European Stocks Turn In Mixed Performance

European Stocks Turn In Mixed Performance

European stocks turned in a mixed performance on Friday as investors amid uncertainty about the outlook for growth as the Trump Administration's fresh and stringent tariffs of 25% on goods from Canada and Mexico, and an additional 10% levy on Chinese imports are set to commence from next week.
RTTNews | 8小时39分钟前